Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effectiveness of the BNT162b2 Vaccine after Recovery from Covid-19
Ariel Hammerman, Ruslan Sergienko, Michael Friger, et al.
New England Journal of Medicine (2022) Vol. 386, Iss. 13, pp. 1221-1229
Open Access | Times Cited: 115

Showing 1-25 of 115 citing articles:

Effectiveness of a second BNT162b2 booster vaccine against hospitalization and death from COVID-19 in adults aged over 60 years
Ronen Arbel, Ruslan Sergienko, Michael Friger, et al.
Nature Medicine (2022) Vol. 28, Iss. 7, pp. 1486-1490
Open Access | Times Cited: 131
Durability of Vaccine-Induced and Natural Immunity Against COVID-19: A Narrative Review
Nick Pooley, Salim S. Abdool Karim, Béhazine Combadière, et al.
Infectious Diseases and Therapy (2023) Vol. 12, Iss. 2, pp. 367-387
Open Access | Times Cited: 64
Severity and Outcomes of SARS-CoV-2 Reinfection Compared with Primary Infection: A Systematic Review and Meta-Analysis
Jie Deng, Yirui Ma, Qiao Liu, et al.
International Journal of Environmental Research and Public Health (2023) Vol. 20, Iss. 4, pp. 3335-3335
Open Access | Times Cited: 44
Association of Receipt of the Fourth BNT162b2 Dose With Omicron Infection and COVID-19 Hospitalizations Among Residents of Long-term Care Facilities
Khitam Muhsen, Nimrod Maimon, Amiel Yaron Mizrahi, et al.
JAMA Internal Medicine (2022) Vol. 182, Iss. 8, pp. 859-859
Open Access | Times Cited: 46
Estimated Protection of Prior SARS-CoV-2 Infection Against Reinfection With the Omicron Variant Among Messenger RNA–Vaccinated and Nonvaccinated Individuals in Quebec, Canada
Sara Carazo, Danuta M. Skowronski, Marc Brisson, et al.
JAMA Network Open (2022) Vol. 5, Iss. 10, pp. e2236670-e2236670
Open Access | Times Cited: 45
Serial cross-sectional estimation of vaccine-and infection-induced SARS-CoV-2 seroprevalence in British Columbia, Canada
Danuta M. Skowronski, Samantha E Kaweski, Michael A. Irvine, et al.
Canadian Medical Association Journal (2022) Vol. 194, Iss. 47, pp. E1599-E1609
Open Access | Times Cited: 45
Vaccine effectiveness against SARS-CoV-2 reinfection during periods of Alpha, Delta, or Omicron dominance: A Danish nationwide study
Katrine Finderup Nielsen, Ida Rask Moustsen-Helms, Astrid Blicher Schelde, et al.
PLoS Medicine (2022) Vol. 19, Iss. 11, pp. e1004037-e1004037
Open Access | Times Cited: 43
BNT162b2 vaccine protection against omicron and effect of previous infection variant and vaccination sequence among children and adolescents in Singapore: a population-based cohort study
Chee Fu Yung, Deanette Pang, Kai‐Qian Kam, et al.
The Lancet Child & Adolescent Health (2023) Vol. 7, Iss. 7, pp. 463-470
Open Access | Times Cited: 25
Biological rhythms in COVID-19 vaccine effectiveness in an observational cohort study of 1.5 million patients
Guy Hazan, Or Duek, Hillel Alapi, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 11
Open Access | Times Cited: 24
COVID-19 vaccines reduce the risk of SARS-CoV-2 reinfection and hospitalization: Meta-analysis
Maria Elena Flacco, Cecilia Acuti Martellucci, Valentina Baccolini, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 35
Effectiveness Associated With Vaccination After COVID-19 Recovery in Preventing Reinfection
Nickolas Lewis, Laura C. Chambers, Huong T. Chu, et al.
JAMA Network Open (2022) Vol. 5, Iss. 7, pp. e2223917-e2223917
Open Access | Times Cited: 33
SARS-CoV-2—The Role of Natural Immunity: A Narrative Review
Sara Diani, Erika Leonardi, Attilio Cavezzi, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 21, pp. 6272-6272
Open Access | Times Cited: 33
Antibody Response to SARS-CoV-2 Vaccines in People with Severe Obesity
Zehra Kara, Rüveyda Akçin, Ahmet Numan Demir, et al.
Obesity Surgery (2022) Vol. 32, Iss. 9, pp. 2987-2993
Open Access | Times Cited: 31
How I treat and prevent COVID-19 in patients with hematologic malignancies and recipients of cellular therapies
Firas El Chaer, Jeffery J. Auletta, Roy F. Chemaly
Blood (2022) Vol. 140, Iss. 7, pp. 673-684
Open Access | Times Cited: 28
Immune correlates of protection for SARS-CoV-2, Ebola and Nipah virus infection
Beatriz Escudero-Pérez, Philip Lawrence, Javier Castillo‐Olivares
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 16
Perceived social support and self-stigma as factors of COVID-19 booster vaccination behavior and intention via cognitive coping and emotion regulation among people infected with COVID-19 in Hong Kong
Xiaoying Zhang, Yang Luan, Yihan Tang, et al.
BMC Public Health (2025) Vol. 25, Iss. 1
Open Access
Omicron BA.1/1.1 SARS-CoV-2 Infection among Vaccinated Canadian Adults
Patrick Brown, Sze Hang Fu, Aiyush Bansal, et al.
New England Journal of Medicine (2022) Vol. 386, Iss. 24, pp. 2337-2339
Open Access | Times Cited: 26
Vaccine effectiveness of the mRNA-1273 3-dose primary series against COVID-19 in an immunocompromised population: A prospective observational cohort study
Jennifer H. Ku, Lina S. Sy, Lei Qian, et al.
Vaccine (2023) Vol. 41, Iss. 24, pp. 3636-3646
Open Access | Times Cited: 13
Protection afforded by post-infection SARS-CoV-2 vaccine doses: A cohort study in Shanghai
Bo Zheng, Bronner P. Gonçalves, Pengfei Deng, et al.
eLife (2025) Vol. 13
Open Access
A call for immediate action to increase COVID-19 vaccination uptake to prepare for the third pandemic winter
Cornelia Betsch, Philipp Schmid, Pierre Verger, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 21
Primary SARS-CoV-2 Infections, Re-infections and Vaccine Effectiveness during the Omicron Transmission Period in Healthcare Workers of Trieste and Gorizia (Northeast Italy), 1 December 2021–31 May 2022
Luca Cegolon, Corrado Negro, Giuseppe Mastrangelo, et al.
Viruses (2022) Vol. 14, Iss. 12, pp. 2688-2688
Open Access | Times Cited: 21
Protection against Omicron re-infection conferred by prior heterologous SARS-CoV-2 infection, with and without mRNA vaccination
Sara Carazo, Danuta M. Skowronski, Marc Brisson, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 19
Breakthrough infections with the SARS-CoV-2 omicron (B.1.1.529) variant in patients with immune-mediated inflammatory diseases
Eileen W Stalman, Luuk Wieske, Koos P J van Dam, et al.
Annals of the Rheumatic Diseases (2022) Vol. 81, Iss. 12, pp. 1757-1766
Open Access | Times Cited: 19
An Immunological Review of SARS-CoV-2 Infection and Vaccine Serology: Innate and Adaptive Responses to mRNA, Adenovirus, Inactivated and Protein Subunit Vaccines
Suhaila A. Al-Sheboul, Brent Brown, Yasemin Shboul, et al.
Vaccines (2022) Vol. 11, Iss. 1, pp. 51-51
Open Access | Times Cited: 18
Characteristics and clinical outcomes of patients with COVID-19 recurrent infection during the omicron variant predominance
Ran Abuhasira, Nitzan Burrack, Lior Nesher, et al.
European Journal of Internal Medicine (2023) Vol. 114, pp. 131-134
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top